Articles d'experts
21 novembre 2022
A tool for finding misrepresentation in life insurance portfolios
Scor (PAR) : 23.44 EUR (-1.84%)
22/11/2024 17:35
A tool for finding misrepresentation in life insurance portfolios
SCOR se mobilise pour restaurer sa rentabilité dans un environnement difficile
85% of nasopharyngeal cancer patients are from Asia. Early detection increases survival rate by nearly 30%.